UNSPSC 51473403: Octenidine dihydrochloride

This classification denotes an anti-infective agent with the molecular formula C36H62N4.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U84956NU4B, chemically known as 1-octanamine, n,n'-(1,10-decanediyldi-1(4h)-pyridinyl-4-ylidene)bis-, dihydrochloride, but more generally known as octenidine dihydrochloride, which bears US NIH Compound Identifier 51166. European Medicines Agency schedules octenidine dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09411MIG.

Most nations, for tariff purposes, schedule octenidine dihydrochloride under HS 29333999. SMILES: CCCCCCCCN=C1CCN(CC1)CCCCCCCCCCN2CCC(=NCCCCCCCC)CC2.CL.CL.

UNSPSC 51473403 Octenidine dihydrochloride (Commodity) represents antimicrobial compounds that state and local governments procure primarily as components of janitorial, operational, and healthcare supply contracts rather than as standalone chemical purchases. The code sees activity across county procurement offices and multistate cooperative purchasing alliances serving healthcare facilities, fire departments, and government operations. Octenidine dihydrochloride enters state and local procurement channels as a specified active ingredient within disinfectant, antiseptic, and cleaning formulations, typically bundled with other consumable supplies on as-needed basis contracts rather than purchased in bulk chemical form.

Recent solicitation activity includes Hillsborough County Board of County Commissioners' ITB2600319 for janitorial and operational supplies (due July 24, 2026, with an estimated contract value of $765,679.84 for one year) serving 47 fire stations, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products (due March 26, 2026) serving participating state and local government facilities across Minnesota and Oregon. The MMCAP procurement emphasizes FDA compliance, cGMP certification, and Drug Supply Chain Security Act adherence, with a two-year contract term and optional extensions. Activity concentrates in the upper Midwest and Southeast, with multistate cooperative vehicles emerging as a primary procurement mechanism for distributing pharmaceutical and antiseptic-containing products across multiple jurisdictions simultaneously.